Marco Paliza-Carre

Marco Paliza-Carre, PhD, is a scientist at aditXt (Nasdaq ADTX) since April 2021, where contributions include developing a patented cell-free enzymatic methylation method for therapeutic applications, creating a gel-based quantitative analysis method for DNA methylation, and supporting preclinical development for ADI-100. Prior to this role, Marco Paliza-Carre was a Graduate Student Researcher at the University of California, Berkeley from January 2012 to March 2021, generating KSHV mutant libraries and analyzing viral life cycles, among other responsibilities. Marco Paliza-Carre holds a PhD in Comparative Biochemistry and a Bachelor of Arts in Molecular and Cell Biology from the University of California, Berkeley.